{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:46:16Z","timestamp":1761630376580},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T00:00:00Z","timestamp":1576627200000},"content-version":"vor","delay-in-days":5344,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1093\/annonc\/mdi809","type":"journal-article","created":{"date-parts":[[2005,5,11]],"date-time":"2005-05-11T17:39:22Z","timestamp":1115833162000},"page":"i66-i68","source":"Crossref","is-referenced-by-count":11,"special_numbering":"S1","title":["ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cutaneous malignant melanoma"],"prefix":"10.1016","volume":"16","author":[{"given":"L.M.","family":"Jost","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Jelic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Purkalne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdi809_bb0005","first-page":"1314","article-title":"Diagnosis and treatment of early melanoma","volume":"288","year":"1992","journal-title":"JAMA"},{"key":"10.1093\/annonc\/mdi809_bb0010","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1200\/JCO.1999.17.5.1508","article-title":"Prospective study of FDG-PET imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy","volume":"17","author":"Wagner","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdi809_bb0015","series-title":"Cancer Staging Handbook: TNM Classification of Malignant Tumors","year":"2002"},{"key":"10.1093\/annonc\/mdi809_bb0020","first-page":"101","article-title":"Long-term results of a prospective surgical trial comparing 2 cm v","volume":"8","author":"Balch","year":"2001","journal-title":"4 cm excision margins for 740 patients with 1\u20134mm melanomas. Ann Surg Oncol"},{"key":"10.1093\/annonc\/mdi809_bb0025","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJMoa030681","article-title":"Excision margins in high-risk malignant melanoma","volume":"350","author":"Thomas","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdi809_bb0030","first-page":"793","article-title":"Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: A randomised trial","volume":"351","author":"Cascinelli","year":"1998","journal-title":"WHO Melanoma Programme. Lancet"},{"key":"10.1093\/annonc\/mdi809_bb0035","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1002\/cncr.20166","volume":"100","author":"Agarwala","year":"2004","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdi809_bb0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JCO.1996.14.1.7","article-title":"Interferon-a-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST-1684","volume":"14","author":"Kirkwood","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdi809_bb0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1200\/JCO.2004.03.185","article-title":"Adjuvant interferon in high-risk melanoma: the AIM HIGH Study-United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanoma","volume":"22","author":"Hancock","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdi809_bb0050","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/pon.770","article-title":"Longitudinal course of depression, fatigue, and quality of life in patients with high risk melanoma receiving adjuvant interferon","volume":"13","author":"Trask","year":"2004","journal-title":"Psychooncology"},{"key":"10.1093\/annonc\/mdi809_bb0055","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00008390-199910000-00009","article-title":"Isolated limb perfusion with tumor necrosis factor-alpha and melphalan with or without interferon- gamma for the treatment of in-transit melanoma metastases: a multicentre randomized phase II study","volume":"9","author":"Lienard","year":"1999","journal-title":"Melanoma Res"},{"key":"10.1093\/annonc\/mdi809_bb0060","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1200\/JCO.2000.18.1.158","article-title":"Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma","volume":"18","author":"Middleton","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdi809_bb0065","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1200\/JCO.2004.10.212","article-title":"Immunologic and clinical outcomes of vaccination with a multiepitope melanoma peptide vaccine plus low-dose interleukin-2 administered either concurrently or on a delayed schedule","volume":"22","author":"Slingluff","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdi809_bb0070","first-page":"566","article-title":"Melanoma recurrence surveillance","volume":"221","author":"Shumate","year":"1995","journal-title":"Patient or physician based? Ann Surg."}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419414828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419414828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/16\/suppl_1\/i66\/966572\/mdi809.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T03:21:51Z","timestamp":1589426511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419414828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":14,"alternative-id":["S0923753419414828"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdi809","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}